Integrin Targeted Innovation

Cerapedics is developing several biologic bone graft products based on the combination of its proprietary anorganic bone mineral (ABM) and a synthetic small peptide (P-15^TM), sold under the name of i-FACTOR^TM. ABM/P-15 products are intended to replace or augment the use of autograft bone commonly utilized in procedures such as: spinal fusion incorporating interbody devices, treatment of non-union, traumatic fresh fractures, and as a bone void filler associated with orthopedic reconstructions.